Physician Attitudes toward the Use of Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium difficile Infection

Jonathan S Zipursky; Tivon I Sidorsky; Carolyn A Freedman; Misha N Sidorsky; Kathryn B Kirkland

doi:10.1155/2014/403828

Canadian Journal of Gastroenterology and Hepatology (Jan 2014)

Physician Attitudes toward the Use of Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium difficile Infection

Jonathan S Zipursky,
Tivon I Sidorsky,
Carolyn A Freedman,
Misha N Sidorsky,
Kathryn B Kirkland

Affiliations

Jonathan S Zipursky: Faculty of Medicine, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA
Tivon I Sidorsky: Department of Dermatology, University of California, San Francisco, California, USA
Carolyn A Freedman: University of Toronto Faculty of Medicine, Toronto, Ontario, Canada
Misha N Sidorsky: Dartmouth College, Hanover, USA
Kathryn B Kirkland: Section of Infectious Diseases and International Health, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA

DOI: https://doi.org/10.1155/2014/403828
Journal volume & issue: Vol. 28, no. 6
pp. 319 – 324

Abstract

Read online

BACKGROUND: Fecal microbiota transplantation (FMT) is a safe and effective, yet infrequently used therapy for recurrent Clostridium difficile infection (CDI).

Published in Canadian Journal of Gastroenterology and Hepatology

ISSN: 2291-2789 (Print); 2291-2797 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology
Website: https://onlinelibrary.wiley.com/journal/1720

About the journal